 |
 |
IIR Seminar: DRA Impact on the MDRP and Other Stakeholders
Attend the IIR DRA Seminar this July in Baltimore and take part in an operational and strategic examination of the Deficit Reduction Act as it impacts the MDRP as soon as the final guidance is issued.
Read more>>
|
 |
 |
Final Rule Makes Modifications to DRA Operational Requirements
The Centers for Medicare and Medicaid Services (CMS) recently released the highly anticipated DRA AMP final rule with comment period. We’ve provided details on a few of the major differences between the proposed and final rules. Read more >> |
 |
 |
DRA 2005 - A Strategic Opportunity to Re-Architect Government Pricing and Medicaid Systems
The passage of the Deficit Reduction Act of 2005 has once again put the spotlight on the industry's pricing and contract
strategies in the context of Goverment Pricing and Medicaid requirements.
Read more >> |
 |
 |
Reports, White Papers, and other Essential DRA Information
The Resources Page features regularly updated content on important issues surrounding the DRA. This month's featured resource is a copy of the CMS' Final DRA Rule as posted to the Federal Register.
Read more >> |
 |
 |
CMS Final Rule Survey
As the pharmaceutical and biotech industry evaluates the impact of the DRA AMP final rule, Model N solicits your help in completing a broad ranging assessment across industry of the major changes and operational impact created by the final rule.
Please take a few minutes to complete the short survey. Model N will present collated results at the IIR DRA conference in Baltimore on July 27 and will post them to dra.modeln.com. Individual responses will be kept strictly confidential.
Take Survey >> |
|
|